These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 21931937)
1. An autophagy inhibitor enhances the inhibition of cell proliferation induced by a proteasome inhibitor in MCF-7 cells. Yao F; Wang G; Wei W; Tu Y; Tong H; Sun S Mol Med Rep; 2012 Jan; 5(1):84-8. PubMed ID: 21931937 [TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma. Hui B; Shi YH; Ding ZB; Zhou J; Gu CY; Peng YF; Yang H; Liu WR; Shi GM; Fan J Cancer; 2012 Nov; 118(22):5560-71. PubMed ID: 22517429 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of autophagy enhances apoptosis induced by proteasome inhibitor bortezomib in human glioblastoma U87 and U251 cells. Zhang X; Li W; Wang C; Leng X; Lian S; Feng J; Li J; Wang H Mol Cell Biochem; 2014 Jan; 385(1-2):265-75. PubMed ID: 24104452 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of autophagy induced by proteasome inhibition increases cell death in human SHG-44 glioma cells. Ge PF; Zhang JZ; Wang XF; Meng FK; Li WC; Luan YX; Ling F; Luo YN Acta Pharmacol Sin; 2009 Jul; 30(7):1046-52. PubMed ID: 19575007 [TBL] [Abstract][Full Text] [Related]
5. Effect of inhibition of the ubiquitin-proteasome system and Hsp90 on growth and survival of rhabdomyosarcoma cells in vitro. Peron M; Bonvini P; Rosolen A BMC Cancer; 2012 Jun; 12():233. PubMed ID: 22691173 [TBL] [Abstract][Full Text] [Related]
6. Bortezomib induces autophagic death in proliferating human endothelial cells. Belloni D; Veschini L; Foglieni C; Dell'Antonio G; Caligaris-Cappio F; Ferrarini M; Ferrero E Exp Cell Res; 2010 Apr; 316(6):1010-8. PubMed ID: 19917281 [TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Zhu K; Dunner K; McConkey DJ Oncogene; 2010 Jan; 29(3):451-62. PubMed ID: 19881538 [TBL] [Abstract][Full Text] [Related]
8. Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation. Kao C; Chao A; Tsai CL; Chuang WC; Huang WP; Chen GC; Lin CY; Wang TH; Wang HS; Lai CH Cell Death Dis; 2014 Nov; 5(11):e1510. PubMed ID: 25375375 [TBL] [Abstract][Full Text] [Related]
9. Bortezomib induces protective autophagy through AMP-activated protein kinase activation in cultured pancreatic and colorectal cancer cells. Min H; Xu M; Chen ZR; Zhou JD; Huang M; Zheng K; Zou XP Cancer Chemother Pharmacol; 2014 Jul; 74(1):167-76. PubMed ID: 24842158 [TBL] [Abstract][Full Text] [Related]
11. Autophagic-lysosomal inhibition compromises ubiquitin-proteasome system performance in a p62 dependent manner in cardiomyocytes. Tian Z; Wang C; Hu C; Tian Y; Liu J; Wang X PLoS One; 2014; 9(6):e100715. PubMed ID: 24959866 [TBL] [Abstract][Full Text] [Related]
12. Induction of autophagy by proteasome inhibitor is associated with proliferative arrest in colon cancer cells. Wu WK; Wu YC; Yu L; Li ZJ; Sung JJ; Cho CH Biochem Biophys Res Commun; 2008 Sep; 374(2):258-63. PubMed ID: 18638451 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. Mimnaugh EG; Xu W; Vos M; Yuan X; Isaacs JS; Bisht KS; Gius D; Neckers L Mol Cancer Ther; 2004 May; 3(5):551-66. PubMed ID: 15141013 [TBL] [Abstract][Full Text] [Related]
14. BAG3 induction is required to mitigate proteotoxicity via selective autophagy following inhibition of constitutive protein degradation pathways. Rapino F; Jung M; Fulda S Oncogene; 2014 Mar; 33(13):1713-24. PubMed ID: 23644654 [TBL] [Abstract][Full Text] [Related]
15. Bortezomib blocks the catabolic process of autophagy via a cathepsin-dependent mechanism, affects endoplasmic reticulum stress and induces caspase-dependent cell death in antiestrogen-sensitive and resistant ER+ breast cancer cells. Periyasamy-Thandavan S; Jackson WH; Samaddar JS; Erickson B; Barrett JR; Raney L; Gopal E; Ganapathy V; Hill WD; Bhalla KN; Schoenlein PV Autophagy; 2010 Jan; 6(1):19-35. PubMed ID: 20110775 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1. Fang J; Rhyasen G; Bolanos L; Rasch C; Varney M; Wunderlich M; Goyama S; Jansen G; Cloos J; Rigolino C; Cortelezzi A; Mulloy JC; Oliva EN; Cuzzola M; Starczynowski DT Blood; 2012 Jul; 120(4):858-67. PubMed ID: 22685174 [TBL] [Abstract][Full Text] [Related]
17. Cancerous inhibitor of protein phosphatase 2A mediates bortezomib-induced autophagy in hepatocellular carcinoma independent of proteasome. Yu HC; Hou DR; Liu CY; Lin CS; Shiau CW; Cheng AL; Chen KF PLoS One; 2013; 8(2):e55705. PubMed ID: 23383345 [TBL] [Abstract][Full Text] [Related]
18. Combination therapy targeting ectopic ATP synthase and 26S proteasome induces ER stress in breast cancer cells. Chang HY; Huang TC; Chen NN; Huang HC; Juan HF Cell Death Dis; 2014 Nov; 5(11):e1540. PubMed ID: 25429617 [TBL] [Abstract][Full Text] [Related]
19. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Ding WX; Ni HM; Gao W; Yoshimori T; Stolz DB; Ron D; Yin XM Am J Pathol; 2007 Aug; 171(2):513-24. PubMed ID: 17620365 [TBL] [Abstract][Full Text] [Related]
20. Oncogenic transformation confers a selective susceptibility to the combined suppression of the proteasome and autophagy. Ding WX; Ni HM; Gao W; Chen X; Kang JH; Stolz DB; Liu J; Yin XM Mol Cancer Ther; 2009 Jul; 8(7):2036-45. PubMed ID: 19584239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]